[Sexual/intimate morbidity under tamoxifen and risk of weakened treatment adherence in premenopausal women with HR+ breast cancer: An underestimated and potentially modifiable factor].
INTRODUCTION In premenopausal women with hormone-sensitive breast cancer, long-term tamoxifen is a standard treatment. However, its adverse effects, particularly on sexual/intimate life, can affect medication adherence. OBJECTIVE To evaluate the impact of this specific toxicity in this population. METHODS A cross-s...